Valion Bio receives first FDA-precedent study protocol from NIAID for Entolimod; federal agency to fully fund BLA-enabling in vivo program and co-navigate FDA submission

Published: 2026-05-05 08:51:02 ET TIVC

Published on 05/05/2026 at 08:51 am EDT